H.R. 865House108th Congress (2003-2005)In Committee

Smallpox Vaccine Compensation and Safety Act of 2003

Introduced February 13, 2003

Legislative Activity

Stay on top of the latest movement without scrolling through every action

5 earlier actions
HouseCommittee Latest Action

Referred to the Subcommittee on Workforce Protections.

March 10, 2003

View full timeline
HouseIntro Referral

Introduced in House

February 13, 2003

HouseIntro Referral

Sponsor introductory remarks on measure. (CR E268)

February 13, 2003

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

February 13, 2003

HouseCommittee

Referred to the Subcommittee on Health.

February 26, 2003

HouseCommittee

Referred to the Subcommittee on Employer-Employee Relations.

March 10, 2003

HouseCommittee

Referred to the Subcommittee on Workforce Protections.

March 10, 2003

Floor Debate

22 members

What members said about H.R. 865 on the floor

6 Republicans16 Democrats
Henry A. Waxman
Rep. Henry A. WaxmanD-CA-30 · Mar 31, 2003

Mr. Speaker, I thank my colleague very much for yielding me time to speak on this issue, and I do so with a great deal of regret because on the House floor today we should be backing a bill on a…

W. J. (Billy) Tauzin
Rep. W. J. (Billy) TauzinR-LA-3 · Mar 31, 2003

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1463) to provide benefits for certain individuals with injuries resulting from administration of a smallpox vaccine, and for other…

Lois Capps
Rep. Lois CappsD-CA-23 · Mar 31, 2003

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, this is an important issue, important to the health and safety of our Nation. Recent tragedies in the health care community have…

Benjamin L. Cardin
Rep. Benjamin L. CardinD-MD-3 · Mar 31, 2003

Mr. Speaker, I rise in opposition to H.R. 1463. The House should be considering a bill today that responds to two basic questions: how do we encourage first responders--nurses, emergency room…

Nancy Pelosi
Rep. Nancy PelosiD-CA-8 · Mar 31, 2003

Mr. Speaker, I had hoped to come to the Floor today with a bill I could recommend to my colleagues on both sides of the aisle. We had been working together, over the past few days, in serious…

Show 8 more
Janice D. Schakowsky
Rep. Janice D. SchakowskyD-IL-9 · Mar 31, 2003

Mr. Speaker, the Smallpox Emergency Personnel Protection Act (H.R. 1463) is being rushed to the House floor today for a vote under suspension, denying us the opportunity to amend this bill to ensure…

Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Mar 31, 2003

Mr. Speaker, I cannot support H.R. 1463, the Smallpox Vaccination Compensation Act. Our nation's first responders and health care workers take risks every day in order to serve the public good. Our…

Fortney Pete Stark
Rep. Fortney Pete StarkD-CA-13 · Mar 31, 2003

Mr. Speaker, I rise in opposition to H.R. 1463, the Smallpox Emergency Personnel Protection Act. This Republican legislation has a lot more to do with public relations than protecting our first…

Tom Udall
Rep. Tom UdallD-NM-3 · Mar 31, 2003

Mr. Speaker, I rise in opposition to the Small Pox Vaccination Compensation Fund Act. We should give pause about voting for a smallpox bill that does not safeguard the health, safety and livelihood…

Sherrod Brown
Rep. Sherrod BrownD-OH-13 · Mar 31, 2003

Mr. Speaker. This isn't, or shouldn't be, a partisan debate. Democrats and Republican members of Congress are in the same boat. The question we have to answer for ourselves is: do we vote ``yes'' to…

Ted Strickland
Rep. Ted StricklandD-OH-6 · Mar 31, 2003

Mr. Speaker, I am truly puzzled at the leadership on the other side. We are told that the administration sent this bill over here as an emergency. Yet I think they know that this bill is likely to be…

John A. Boehner
Rep. John A. BoehnerR-OH-8 · Mar 31, 2003

Mr. Speaker, I want to thank my colleague for yielding me the time. Mr. Speaker, I rise today in support of this important legislation to establish a compensation program for our Nation's emergency…

Sander M. Levin
Rep. Sander M. LevinD-MI-12 · Mar 31, 2003

Mr. Speaker, since September 11, we have begun to prepare for a number of events that once seemed unthinkable. One of them is an epidemic of smallpox, a deadly disease that we thought we had erased…

Show 9 more
Richard Burr
Rep. Richard BurrR-NC-5 · Mar 31, 2003

Mr. Speaker, this legislation, ``The Smallpox Emergency Personnel Protection Act,'' is another positive step towards preparing our citizens for a bioterrorist attack. For more than 2 years, I have…

John D. Dingell
Rep. John D. DingellD-MI-15 · Mar 31, 2003

Mr. Speaker, I join the millions of our Nation's first responders in opposition to H.R. 1463, the Smallpox Emergency Personnel Protection Act of 2003.'' Right after we defeat this bill, I hope that…

Michael C. Burgess
Rep. Michael C. BurgessR-TX-26 · Mar 31, 2003

Mr. Speaker, I thank the gentleman for yielding me this time, and today I rise in support of H.R. 1463, the Smallpox Emergency Personnel Act of 2003. I will just add, in light of the comments made by…

Christopher Cox
Rep. Christopher CoxR-CA-48 · Mar 31, 2003

Mr. Speaker, we are here in extraordinary circumstances, rushing this legislation to the floor as we must, because we are facing an emergency. We have got to provide compensation to those workers who…

Rush Holt
Rep. Rush HoltD-NJ-12 · Mar 31, 2003

Mr. Speaker, on September 11, 2001, as thousands fled over lower Manhattan during the terrorist strikes, many ran towards the burning buildings. These brave men and women were first responders--the…

Edolphus Towns
Rep. Edolphus TownsD-NY-10 · Mar 31, 2003

Mr. Speaker, I rise today in opposition to H.R. 1463. While it offers significant liability protections to those entities that are responsible for administering the vaccination program, it simply…

F. James Sensenbrenner, Jr.
Rep. F. James Sensenbrenner, Jr.R-WI-5 · Mar 31, 2003

Mr. Speaker, the bill before the House today, H.R. 1463 contains several provisions that are within the jurisdiction of the House Committee on the Judiciary as provided in Rule X of the Rules of the…

Mark Udall
Rep. Mark UdallD-CO-2 · Mar 31, 2003

Mr. Speaker, I regret that I cannot support this bill. When President Bush called for the voluntary vaccination against smallpox of 500,000 health care workers and other first responders last…

Edward J. Markey
Rep. Edward J. MarkeyD-MA-7 · Mar 31, 2003

Mr. Speaker, who opposes this bill? The nurses, the police, the fire, the Public Health Association of the United States. They all oppose it. These are the health care heroes in our country. The…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued February 13, 2003
        [Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 865 Introduced in House (IH)]

108th CONGRESS
1st Session
H. R. 865

To protect the health and safety of individuals receiving smallpox
vaccinations and to provide compensation and assured access to care for
individuals injured by the vaccine, and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

February 13, 2003

Mr. Waxman (for himself, Mr. Brown of Ohio, Mrs. Capps, and Mr. Markey)
introduced the following bill; which was referred to the Committee on
Energy and Commerce, and in addition to the Committee on Education and
the Workforce, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned

_______________________________________________________________________

A BILL

To protect the health and safety of individuals receiving smallpox
vaccinations and to provide compensation and assured access to care for
individuals injured by the vaccine, and for other purposes.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Smallpox Vaccine Compensation and
Safety Act of 2003''.

SEC. 2. SMALLPOX VACCINATIONS.

The Public Health Service Act (42 U.S.C. 201 et seq.) is amended by
adding at the end the following:

``TITLE XXIX--ADDITIONAL VACCINE PROVISIONS

``SEC. 2901. COVERED COUNTERMEASURE.

``For purposes of this title, the terms ``covered countermeasure''
and ``covered countermeasure against smallpox'' have the meanings given
to those terms in section 224(p)(7)(A).

``SEC. 2902. GRANTS TO ASSIST STATE AND LOCAL GOVERNMENTS IN MEETING
THE COSTS OF SMALLPOX INOCULATION PROGRAMS.

``(a) In General.--
``(1) Grants.--For the purposes described in paragraph (2),
the Secretary shall make an allotment each fiscal year for each
State in an amount determined in accordance with subsection
(e). The Secretary shall make a grant to the State of the
allotment made for the State for the fiscal year if the State
submits to the Secretary an application at such time, in such
manner, and containing such information as the Secretary may
require.
``(2) Purposes.--A funding agreement for a grant under this
section is that the State involved will expend the grant only
for the following purposes:
``(A) Providing for the administration of covered
countermeasures against smallpox.
``(B) Monitoring the health of individuals
receiving covered countermeasures against smallpox or
individuals in close contact with individuals receiving
such countermeasures.
``(C) Providing for the conduct of epidemiological
studies related to the administration of covered
countermeasures against smallpox.
``(b) Supplement Not Supplant.--A funding agreement for a grant
under this section is that the State involved will use the grant to
supplement and not supplant funds received from other sources for the
purposes described in subsection (a).
``(c) Local Involvement.--A funding agreement for a grant under
this section is that the State involved will ensure that a suitable
portion of the amount received under the grant is expended at the local
level.
``(d) Requirements.--
``(1) In general.--A funding agreement for a grant under
this section is that the State involved will comply with the
requirements of this subsection.
``(2) Education program.--
``(A) Establishment.--Each State that receives a
grant under this section shall establish an education
program to provide to each individual to whom a covered
countermeasure against smallpox is proposed to be
administered an explanation of--
``(i) the screening and medical
surveillance and evaluation programs available
under paragraphs (3) and (4);
``(ii) the risks and benefits from
administration of such countermeasure for such
individuals and those individuals with whom
they have close contact;
``(iii) the availability of the
compensation program under section 224(q);
``(iv) the eligibility of the individual to
receive health care as described in this Act;
``(v) the right of the individual to refuse
the administration of any covered
countermeasure against smallpox;
``(vi) the right of an individual who
exercises the option described in clause (v) to
be protected from disciplinary action under
section 2903; and
``(vii) the general functions and duties
that such individual may be expected to carry
out if there is a smallpox outbreak.
``(B) Explanations.--Explanations provided under
subparagraph (A)--
``(i) shall be made available in a form
that is easily read and understood;
``(ii) shall be provided, as appropriate,
in languages other than English;
``(iii) shall be made available to those
individuals who reside with individuals to whom
such covered countermeasure is proposed to be
administered and, as appropriate, to patients
treated by individuals who have received a
covered countermeasure; and
``(iv) shall be made available without
charge or loss of wages or benefits to an
individual to whom a covered countermeasure
against smallpox is proposed to be administered
and to the individuals described in clause
(iii).
``(3) Screening program.--
``(A) In general.--Each State that receives a grant
under this section shall, for each individual to whom a
covered countermeasure against smallpox is proposed to
be administered--
``(i) provide without charge counseling
services that describe conditions which may
exacerbate the risks of receiving such
countermeasure; and
``(ii) offer on a voluntary basis,
screening and testing that can identify health
conditions that can reasonably be expected to
significantly increase risks to the health of
such individual, including screening and
testing for human immunodeficiency virus,
eczema or other significant chronic skin
irritation, pregnancy, and such other
conditions as determined appropriate by the
Secretary.
``(B) Results.--The results or other information
(including information concerning an individual's
refusal to be screened or tested) generated or obtained
from the screening and testing described in
subparagraph (A)--
``(i) shall be deemed protected health
information under the meaning of the term in
the regulations promulgated pursuant to the
authority of section 264(c) of the Health
Insurance Portability and Accountability Act of
1996;
``(ii) shall not be made available to an
employer; and
``(iii) shall be provided without charge to
the individual receiving such screening and
testing.
``(4) Medical surveillance and evaluation program.--If the
Secretary declares vaccinia vaccine or any other measure to be
a covered countermeasure under section 224(p), each State that
receives a grant under this section shall ensure that an
ongoing active medical surveillance and evaluation program is
provided to all individuals to whom such countermeasure is
administered and to the close contacts of such individuals.
Such program shall--
``(A) be provided from the date that vaccinia
vaccine or another covered countermeasure is
administered to a date that is not less than 60 days
from the date of administration;
``(B) include evaluation of any adverse health
effect that may reasonably appear to be due to vaccinia
vaccine or another covered countermeasure and shall
provide prompt medical treatment or referral of any individual
requiring health care as a result of such adverse health effect; and
``(C) be provided without charge to any individual
to whom vaccinia vaccine or another covered
countermeasure is administered and to the close
contacts of such individuals.
``(5) Needles.--If the Secretary declares vaccinia vaccine
to be a covered countermeasure under section 224(p), each State
that receives a grant under this section shall ensure that for
any administration of such vaccine, the individual
administering such vaccine shall use a sheathed bifurcated
needle--
``(A) to the extent that such needle is approved
under the Federal Food, Drug, and Cosmetic Act; and
``(B) to the extent that such sheathed bifurcated
needle is available in such State.
``(e) Funding.--
``(1) Authorization of appropriations.--For carrying out
this section, there are authorized to be appropriated
$850,000,000 for fiscal year 2003 and such sums as may be
necessary for each subsequent fiscal year.
``(2) Allocation.--From the amounts appropriated and
available for allotment under this subsection for any fiscal
year, the Secretary shall allot to each State that submits an
application in accordance with subsection (a)(1) an amount that
is the greater of--
``(A) the base amount as determined under paragraph
(3); or
``(B) the minimum amount as determined under
paragraph (4).
``(3) Base amount.--For each State receiving an award under
this section, the Secretary shall determine the base amount,
which shall be equal to the product of--
``(A) the amount appropriated under this subsection
for the fiscal year, less an amount equal to the sum of
all minimum amounts determined for the States under
paragraph (4); and
``(B) the percentage constituted by the ratio of an
amount equal to the population of the State over an
amount equal to the total population of the States (as
indicated by the most recent data collected by the
Bureau of the Census).
``(4) Minimum amount.--For each State receiving an award
under this subsection, the minimum amount is--
``(A) in the case of each of the several States,
the District of Columbia, and the Commonwealth of
Puerto Rico, an amount equal to the lesser of--
``(i) $5,000,000; or
``(ii) if the amount appropriated under
this subsection is less than $667,000,000, an
amount equal to 0.75 percent of the amount
appropriated under this subsection; or
``(B) in the case of each of American Samoa, Guam,
the Commonwealth of the Northern Mariana Islands, and
the United States Virgin Islands, an amount determined
by the Secretary to be appropriate, except that such
amount may not exceed the amount determined under
subparagraph (A).

``SEC. 2903. PROTECTION FROM DISCIPLINARY ACTION.

``(a) Finding.--The Congress finds that unlawful employment
practices described in subsection (b) are detrimental to the general
public health and an interference with the interstate control of
infectious disease.
``(b) In General.--It shall be an unlawful employment practice for
an employer--
``(1) to fail or refuse to hire or to discharge any
individual, or otherwise to discriminate against any individual
with respect to the compensation, terms, conditions, or
privileges of employment of the individual, because of a
refusal or inability to receive the administration of a covered
countermeasure against smallpox or because of an adverse
reaction or reactions to such countermeasure; or
``(2) subject to subsection (c), to limit, segregate, or
classify the employees of the employer in any way that would
deprive or tend to deprive any individual of employment
opportunities or otherwise adversely affect the status of the
individual as an employee, because of a refusal or inability to
receive a covered countermeasure against smallpox or because of
an adverse reaction or reactions to such countermeasure.
``(c) Exception.--
``(1) In general.--This section does not prohibit an
employer from limiting, segregating, or classifying for a
period of 30 days or less an employee to whom a covered
countermeasure against smallpox has been administered for the
purpose of protecting the close contacts (including patients)
of such employee.
``(2) Regular wages and benefits required.--Nothing in
paragraph (1) shall be construed to permit an employer to
reduce the wages or benefits of an employee because a covered
countermeasure against smallpox has been administered to such
employee.
``(d) Definitions of Employee and Employer.--The terms `employee'
and `employer' have the meanings given such terms in section 701 of the
Civil Rights Act of 1964 (42 U.S.C. 2000e), except that the terms
`employee' and `employer' shall also include the meanings given such
terms in section 717 of the Civil Rights Act of 1964 (42 U.S.C. 2000e-
16).
``(e) Filing Complaints and Procedures.--
``(1) Complaint.--
``(A) In general.--Not later than 180 days after an
alleged violation of subsection (b) has occurred, the
employee alleging such violation or another individual
at the employee's request, may file a complaint with
the Secretary.
``(B) Notice.--Not later than 15 days after receipt
of a complaint described in subparagraph (A), the
Secretary shall notify the employer alleged in the
complaint to have committed a violation of subsection
(b) of the filing of such complaint.
``(2) Findings and preliminary order.--
``(A) In general.--Not later than 60 days after
receiving a complaint described in paragraph (1), the
Secretary shall--
``(i) conduct an investigation of the
matters alleged in the complaint;
``(ii) determine whether it is reasonable
to believe that the complaint has merit; and
``(iii) notify the complainant and the
employer alleged to have committed the
violation of subsection (b) of the
determination.
``(B) Reasonable belief that a violation has
occurred.--If the Secretary determines pursuant to
subparagraph (A) that it is reasonable to believe that
a violation of subsection (b) has occurred, the
Secretary shall include with the notice under such
subparagraph findings and a preliminary order for the
relief provided under paragraph (3).
``(C) Objections.--
``(i) In general.--Not later than 30 days
after receipt of the notice under subparagraph
(A), the complainant and the employer alleged
to have committed the violation of subsection
(b) may file objections to the findings or the
preliminary order and request a hearing on the
record.
``(ii) Reinstatement.--The filing of
objections under clause (i) does not stay a
reinstatement ordered in the preliminary order.
``(iii) Failure to object.--If a hearing is
not requested pursuant to the requirements of
clause (i), the preliminary order is final and
not subject to judicial review.
``(D) Hearings and final order.--
``(i) Hearings.--A hearing under this
subsection shall be conducted expeditiously.
``(ii) Final order.--Not later that 120
days after the end of a hearing under this
subsection, the Secretary shall issue a final
order.
``(iii) Settlement.--At any time prior to
the issuance of a final order, any further
action under this subsection may be ended by a
settlement agreement made by the complainant
and the employer alleged to have committed the
violation of subsection (b), and approved by
the Secretary.
``(3) Relief.--
``(A) In general.--If the Secretary determines on
the basis of a complaint, that an employer violated
subsection (b) of this section, the Secretary shall
order such employer to provide relief including--
``(i) taking affirmative action to abate
the violation;
``(ii) reinstating the complainant to the
former position with the same pay and terms and
privileges of employment; and
``(iii) paying compensatory damages,
including back pay.
``(B) Costs incurred in bringing a complaint.--If
the Secretary issues an order under subparagraph (A),
and the complainant so requests, the Secretary may
order that the employer who violated subsection (b) pay
the costs (including attorney's fees) reasonably
incurred by the complainant in bringing the complaint,
as determined by the Secretary.
``(f) Judicial Review and Venue.--
``(1) In general.--Not later than 60 days after an order
has been issued under subsection (e), a party adversely
affected by such order may file a petition for review in the
United States circuit court for the circuit in which the
violation occurred or in which the party resided on the date of
the violation.
``(2) Review.--A review conducted pursuant to this
subsection shall be heard and decided expeditiously.
``(3) Review in other proceedings.--An order of the
Secretary subject to review under this subsection is not
subject to judicial review in a criminal or other civil
proceeding.
``(g) Civil Actions To Enforce.--If an employer fails to comply
with an order issued under subsection (e), the Secretary shall bring a
civil action to enforce such order in the United States district court
for the district in which the violation occurred.

``SEC. 2904. MEDICAL LEAVE FOR CERTAIN VACCINE RECIPIENTS.

``(a) In General.--In accordance with regulations promulgated by
the Secretary, an employee (as defined in section 3 of the Fair Labor
Standards Act of 1938) shall be entitled to a total of not more than 4
workdays of paid leave because of a health condition that makes the
employee unable to perform the functions of the position of such
employee that arose as a result of the employee having received or come
into close contact with an individual who received a covered
countermeasure against smallpox.
``(b) Application of Certain Provisions.--Leave shall be provided
under subsection (a) in accordance with the provisions of the Family
and Medical Leave Act of 1993 except that--
``(1) such leave shall be provided for a condition
described in subsection (a) regardless of whether such
condition requires inpatient care or continuing treatment;
``(2) such leave shall be fully paid; and
``(3) this section shall apply to all employers regardless
of size.
``(c) Reimbursement From the Program.--
``(1) Non-federal employees.--Any employer, other than a
Federal agency, that provides paid leave to an employee for the
reasons described in subsection (a) may seek reimbursement for
such leave from the compensation program under section 224(q).
``(2) Federal employees.--A Federal agency that provides
leave under this section shall treat such leave as paid
administrative leave.

``SEC. 2905. RESPONSIBILITIES OF THE SECRETARY.

``(a) Supplies of Vaccinia Immune Globulin.--If the Secretary
declares vaccinia vaccine to be a covered countermeasure under section
224(p), the Secretary shall ensure that adequate supplies of vaccinia
immune globulin are made available to any individual to whom vaccinia
vaccine is administered during the period of such declaration.
``(b) Uniform System of Reporting.--
``(1) In general.--The Secretary shall establish a uniform
system for reporting adverse responses to any covered
countermeasure against smallpox to the Secretary.
``(2) Report to congress.--Not later than 1 year after the
date of enactment of this Act and every year in which covered
countermeasures against smallpox are administered, the
Secretary shall submit to the Committee on Health, Education,
Labor, and Pensions of the Senate and the Committee on Energy
and Commerce of the House of Representatives, a report that
describes for the preceding year--
``(A) the number of individuals to whom a covered
countermeasure against smallpox was administered; and
``(B) the number and kind of adverse reactions
caused by the administration of a covered
countermeasure against smallpox.

``SEC. 2906. PROVISION OF NEEDLES.

``The Director of the Centers for Disease Control and Prevention
shall provide needles to States that receive a grant under section 2902
for the purpose of administering vaccinia vaccine in accordance with
section 2902(d)(5).''.

SEC. 3. HEALTH CARE FOR HEALTH CARE WORKERS AND FIRST RESPONDERS
SUFFERING ADVERSE REACTIONS OR COMPLICATIONS FROM
SMALLPOX VACCINE; CONTINUED INSURANCE COVERAGE.

(a) Payments for Provision of Medical Assistance.--Title XXIX of
the Public Health Service Act (as added by section 2) is amended by
adding at the end the following:

``SEC. 2907. HEALTH CARE FOR INDIVIDUALS SUFFERING ADVERSE REACTIONS OR
COMPLICATIONS FROM SMALLPOX VACCINE.

``(a) Payment.--
``(1) In general.--The Secretary shall pay to each State
with an agreement described in subsection (b) an amount equal
to the costs incurred by that State to provide medical
assistance described in subsection (b)(1), subject to paragraph
(2).
``(2) Limitation on payment.--The Secretary shall not make
any payment under paragraph (1) for costs for medical
assistance insofar as such costs may reasonably be reimbursed
from a third party under the terms of the agreement described
in subsection (b)(2). Any payment under this section to a State
with respect to medical assistance shall be conditioned on
reimbursement to the Secretary when notice or other information
is received that payment for such medical assistance has been
or could be made by a third party under subsection (b)(2).
``(b) Agreement.--An agreement described in this subsection is an
agreement between a State and the Secretary in which the State--
``(1) agrees to provide such medical assistance as may be
medically necessary to--
``(A) any health care worker or first responder
who--
``(i) has suffered any adverse reaction or
complication as a result of a covered
countermeasure against smallpox or exposure to
vaccinia virus or any other substance
administered for the prevention or treatment of
smallpox; and
``(ii) has not received compensation under
the National Smallpox Vaccine Injury
Compensation Program established under section
224; and
``(B) any individual who--
``(i) has suffered any adverse reaction or
complication as a result of contact with
another person who received a covered
countermeasure; and
``(ii) has not received compensation under
the National Smallpox Vaccine Injury
Compensation Program established under section
224; and
``(2) agrees to take all reasonable measures to obtain
reimbursement for the costs of providing such assistance from
any third party (including health insurers and group health
plans (as defined in section 2791)) with responsibility for
such costs.
``(c) State Entitlement.--This section constitutes budget authority
in advance of appropriations Acts and represents the obligation of the
Federal Government to provide for the payment to States of amounts
provided under this section.
``(d) Rule of Construction.--
``(1) Insurance coverage.--Nothing in this section shall be
construed to invalidate or otherwise abridge any provision of
law or any contractual obligation that otherwise obligates a
health insurance issuer to provide reimbursement or otherwise
defray the cost to an individual of health care needed to treat
the health consequences of the administration of or exposure to
a covered countermeasure against smallpox or exposure to
vaccinia virus.
``(2) Health care facilities.--Nothing in this section
shall be construed to invalidate or otherwise abridge any
provision of law or any contractual obligation that otherwise
obligates a health care facility to provide health care or
other health services to an individual that are needed to treat
the health consequences of the administration of a covered
countermeasure against smallpox or exposure to vaccinia virus.
``(3) Employers.--Nothing in this section shall be
construed to invalidate or otherwise abridge any provision of
law or any contractual obligation that otherwise obligates an
employer to provide leave, wages, vacation time, or any other
benefit to an individual.
``(4) State or local governments.--Nothing in this section
shall be construed to invalidate or otherwise abridge any
provision of law or any contractual obligation that otherwise
obligates a State or local government to provide health care,
workers' compensation, or any other benefit to an individual.
``(e) Authorizing Utilization of Medicaid in Providing Medical
Assistance.--Nothing in this section shall be construed to prevent a
State from utilizing its medicaid program under title XIX of the Social
Security Act in order to provide medical assistance under this section.
The Secretary shall waive such provisions of such Act as are necessary
to permit a State to so utilize such program under this subsection.''.
(b) Continued Coverage of Benefits for Smallpox Vaccine Side
Effects.--
(1) State maintained plans.--Section 2907 of the Public
Health Service Act (as added by subsection (a)) is amended by
adding at the end the following:
``(f) Continued Coverage of Benefits for Smallpox Vaccine Side
Effects.--
``(1) In general.--In accordance with regulations which the
Secretary shall prescribe, each group health plan that is
maintained by any State that receives funds under this Act, by
any political subdivision of such State, or by any agency or
instrumentality of such State or political subdivision, shall
provide coverage of benefits for side effects resulting from
covered countermeasures against smallpox at the level of such
coverage it provided as of September 10, 2001.
``(2) Enforcement.--For purposes of section 2207, the
requirement of paragraph (1) is deemed a requirement of title
XXII.''.
(2) Private plans.--
(A) Amendment to tax code.--
(i) In general.--Paragraph (1) of section
4980B(f) of the Internal Revenue Code of 1986
is amended by inserting before the period at
the end the following: ``, and (C) only if the
coverage of the side effects from covered
countermeasures against smallpox (as such term
is defined in section 224(p) of the Public
Health Service Act) is not less than the level
of coverage provided by the plan as of
September 10, 2001''.
(ii) Conforming amendments.--Section
4980B(f)(1) of such Code is amended--
(I) by inserting ``(A)'' before
``only if'' the first place it appears,
and
(II) by striking ``and only if''
and inserting ``, (B) only if''.
(iii) Effective date.--The amendments made
by this section shall apply to covered
countermeasures against smallpox taken after
the date of the enactment of this Act.
(B) Amendment to ERISA.--Section 609 of the
Employee Retirement Income Security Act of 1974 (29
U.S.C. 1169) is amended--
(i) by redesignating subsection (e) as
subsection (f); and
(ii) by inserting after subsection (d) the
following:
``(e) Continued Coverage of Benefits for Smallpox Vaccine Side
Effects.--A group health plan shall provide coverage of the side
effects from covered countermeasures against smallpox (as such term is
defined in section 224(p) of the Public Health Service Act) at the
level of coverage provided by the plan as of September 10, 2001.''.

SEC. 4. NATIONAL SMALLPOX VACCINE INJURY COMPENSATION PROGRAM.

(a) Establishment.--Section 224 of the Public Health Service Act
(42 U.S.C. 233), as amended by section 304(c) of Public Law 107-296
(116 Stat. 2135), is amended by adding at the end the following:
``(q) National Smallpox Vaccine Injury Compensation Program.--
``(1) Establishment.--The Secretary shall establish the
National Smallpox Vaccine Injury Compensation Program (referred
to in this subsection as the `Smallpox Program') under which
compensation may be paid for injury or death related to the
administration of any covered countermeasure against smallpox.
``(2) Procedures and standards.--The Secretary shall by
regulation establish procedures and standards applicable to the
Smallpox Program that follow the procedures and standards
applicable under the National Vaccine Injury Compensation
Program established under section 2110, except for the
following:
``(A) A person may not file a civil action under
subsection (p) unless the person has first filed a
petition for compensation under the Smallpox Program
under section 2111.
``(B) After filing a petition under section 2111, a
person may elect to instead bring a civil action under
subsection (p) if the person would be authorized under
clause (i) or (ii) of section 2111(a)(2)(A) and under
section 2121 to elect to bring a civil action.
``(C) Notwithstanding section 2111(c)(1)(A), a
person who did not receive a covered countermeasure
against smallpox or any other substance administered
for the prevention or treatment of smallpox (including
vaccinia virus) may receive compensation under the
Smallpox Program if the person was injured as a result
of contact with another person who received such a
countermeasure or substance.
``(D) Section 2111(c)(1)(D) (requiring petitioner
to demonstrate death, residual effects for more than 6
months, or inpatient hospitalization and surgical
intervention) shall not apply.
``(E) Notwithstanding section 2115(a)(2), in the
event of a death related to the administration of
vaccinia virus or other substance or medication
administered for the purpose of preventing or treating
smallpox (including any covered countermeasure against
smallpox), compensation under the Smallpox Program
shall include an award for the estate of the deceased
of $850,000, in addition to any other compensation to
which the petitioner is entitled under this section.
``(3) Vaccine injury table.--
``(A) Inclusion.--For purposes of receiving
compensation under the Smallpox Program, the Vaccine
Injury Table under section 2114 is deemed to include
the following table of injuries, disabilities,
illnesses, conditions, and deaths resulting from the
administration of the smallpox vaccine, and the time
period in which the first symptom or manifestation of
onset or of significant aggravation of such injuries,
disabilities, illnesses, conditions, and deaths is to
occur after administration of vaccinia virus or other
substance or medication administered for the purpose of
preventing or treating smallpox (including a covered
countermeasure against smallpox):

``Adverse event:           Time period for first
symptom or manifestation
of onset or of
significant aggravation
after administration of
vaccinia virus or other
substance or medication
administered for the
purpose of preventing or
treating smallpox
(including a covered
countermeasure against
smallpox):
A. Anaphylaxis or              0-4 hours
anaphylactic shock......
B. Eczema vaccinatum           any
(including in a contact
case)...................
C. Accidental inoculation      any
(including in a contact
case)...................
D. Progressive vaccinia..      any
E. Encephalopathy (or          0-21 days
encephalitis)...........
F. Stevens-Johnson             3-21 days
syndrome................
G. Generalized vaccinia..      0-60 days
H. Any acute complication      Not applicable
or sequela (including
death) of an illness,
disability, injury, or
condition referred to
above which illness,
disability, injury, or
condition arose within
the time period
prescribed..............

``(B) Rule of construction.--Section 13632 (a)(3)
of Public Law 103-66 (107 Stat. 646) (making revisions
by Secretary to the Vaccine Injury Table effective on
the effective date of a corresponding tax) shall not be
construed to apply to the revision to the Vaccine
Injury Table made by this paragraph.
``(4) Prohibition.--The Secretary may not provide any
compensation under the Smallpox Program for any minor scarring
or minor local reaction.
``(5) Application.--The Smallpox Program applies to any
injury or death associated with the administration of any
covered countermeasure on or after November 25, 2002.
``(6) Reimbursement.--Notwithstanding paragraph (4), the
Secretary may reimburse under this section an employer who
seeks reimbursement pursuant to section 2904.
``(7) Special masters.--
``(A) Hiring.--In accordance with section 2112, the
judges of the United States Claims Court shall appoint
a sufficient number of special masters to address
claims for compensation under this subsection.
``(B) Budget authority.--There are appropriated to
carry out this paragraph such sums as may be necessary
for fiscal year 2003 and each fiscal year thereafter.
This subparagraph constitutes budget authority in
advance of appropriations and represents the obligation
of the Federal Government.
``(8) Covered countermeasure.--For purposes of this
subsection, the terms `covered countermeasure' and `covered
countermeasure against smallpox' have the meanings given to
those terms in subsection (p)(7)(A).
``(9) Funding.--Compensation made under the Smallpox
Program shall be made from the same source of funds as payments
made under subsection (p).''.
(b) Relation to Federal Tort Claims Act.--Paragraph (3) of section
224(p) of the Public Health Service Act (42 U.S.C. 233(p)) is amended
to read as follows:
``(3) Exhaustion; exclusivity.--
``(A)  National smallpox vaccine injury
compensation program.--A person may not bring a claim
under this subsection unless the person has first filed
a petition for compensation under the program
established under subsection (q) and made a proper
election under sections 2111(a)(2)(A) and 2121.
``(B) Exclusivity.--Except for filing a petition
for compensation under the program established under
subsection (q), the remedy provided by subsection (a)
shall be exclusive of any other civil action or
proceeding for any claim or suit this subsection
encompasses, during the effective period of a
declaration by the Secretary under paragraph (2)(A).''.
(c) Persons Susceptible to Vaccine-Related Injury.--Subsection (b)
of section 2114 of the Public Health Service Act (42 U.S.C. 300aa-14)
is amended by adding at the end the following:
``(5) A petitioner shall be considered to have suffered an
injury related to the administration of a covered
countermeasure even if the petitioner might not have suffered
the injury absent an infection, disease, or other condition
that made him or her more susceptible to the injury.''.

SEC. 5. TECHNICAL MODIFICATION.

(a) Circumstances in Which Presumption in Cases of Accidental
Vaccinia Inoculation Applies.--Section 224(p)(2)(C)(ii)(II) of the
Public Health Service Act (42 U.S.C. 233(p)(2)(C)(ii)(II)) is amended
by striking ``resides or has resided with'' and inserting ``has had
close contact with''.
(b) Covered Countermeasure.--Subparagraph (A) of section 224(p)(7)
of the Public Health Service Act (42 U.S.C. 233(p)(7)(A)) is amended to
read as follows:
``(A) Covered countermeasure.--The term `covered
countermeasure', or `covered countermeasure against
smallpox', means a substance specified in a declaration
under paragraph (2) that is--
``(i) a substance used to prevent or treat
smallpox (including vaccinia or another
vaccine); or
``(ii) a substance (including vaccinia
immune globulin and cidofovir) used to control
or treat the adverse effects of vaccinia
inoculation or administration of any other
countermeasure against smallpox.''.
(c) Covered Person.--Section 224(p)(7)(B)(ii) of the Public Health
Service Act (42 U.S.C. 233(p)(7)(B)(ii)) is amended to read as follows:
``(ii) a health care entity, a State, or a
political subdivision of a State under whose
auspices such countermeasure was
administered;''.
(d) Effective Date.--This section shall take effect as of November
25, 2002 (the date of enactment of the Homeland Security Act of 2002
(Pub. L. 107-296; 116 Stat. 2135)).
<all>